PURA VIDA INVESTMENTS, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$15.06M
Insider Sells Quantity
4
Insider Sells Sum
$1.34M

Insider Activity of PURA VIDA INVESTMENTS, LLC

The largest purchase of all time was on 2022-04-14 and amounted to 9856394 shares of OncoCyte Corporation for $13.09M.

The largest sale of all time was on 2019-12-04 and amounted to 150000 shares of Greenlane Holdings, Inc. for $462,750.

Biography of PURA VIDA INVESTMENTS, LLC

No biography is available at this moment.

2023-04-05PurchaseOncoCyte Corporation
OCX
10 percent owner
663,000
0.6681%
$0.30$200,027-37.96%
2022-04-14PurchaseOncoCyte Corporation
OCX
10 percent owner
9.86M
9.1898%
$1.33$13.09M-40.24%
2021-09-15SaleStryve Foods, Inc.
SNAX
10 percent owner
1.6M
–
$0$0-61.13%
2019-12-09SaleGreenlane Holdings, Inc.
GNLN
10 percent owner
150,000
1.5266%
$2.86$429,000+2.17%
2019-12-05SaleGreenlane Holdings, Inc.
GNLN
10 percent owner
150,000
1.5453%
$3.01$451,500-2.08%
2019-12-05PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
150,000
1.5504%
$3.02$453,000-2.08%
2019-12-04SaleGreenlane Holdings, Inc.
GNLN
10 percent owner
150,000
1.4527%
$3.08$462,750-10.19%
2019-12-04PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
150,000
1.4574%
$3.10$464,250-10.19%
2019-09-30PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
20,000
0.1971%
$3.39$67,800-12.68%
2019-09-24PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
50,000
0.5232%
$3.97$198,500-21.08%
2019-09-23PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
40,000
0.401%
$4.25$170,000-29.01%
2019-09-20PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
60,000
0.5935%
$4.49$269,400-33.48%
2019-09-19PurchaseGreenlane Holdings, Inc.
GNLN
10 percent owner
35,000
0.3351%
$4.25$148,750-31.87%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.